241 related articles for article (PubMed ID: 25895872)
1. Engineering the nanoparticle-protein interface for cancer therapeutics.
Saie AA; Ray M; Mahmoudi M; Rotello VM
Cancer Treat Res; 2015; 166():245-73. PubMed ID: 25895872
[TBL] [Abstract][Full Text] [Related]
2. Calibration-quality cancer nanotherapeutics.
Perry JL; Kai MP; Reuter KG; Bowerman C; Christopher Luft J; DeSimone JM
Cancer Treat Res; 2015; 166():275-91. PubMed ID: 25895873
[TBL] [Abstract][Full Text] [Related]
3. Nanodiamond-based chemotherapy and imaging.
Ho D
Cancer Treat Res; 2015; 166():85-102. PubMed ID: 25895865
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
5. Theranostic lipid nanoparticles for cancer medicine.
Charron DM; Chen J; Zheng G
Cancer Treat Res; 2015; 166():103-27. PubMed ID: 25895866
[TBL] [Abstract][Full Text] [Related]
6. Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.
McMahon KM; Foit L; Angeloni NL; Giles FJ; Gordon LI; Thaxton CS
Cancer Treat Res; 2015; 166():129-50. PubMed ID: 25895867
[TBL] [Abstract][Full Text] [Related]
7. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
8. How nanoparticles interact with cancer cells.
Syed A; Chan WC
Cancer Treat Res; 2015; 166():227-44. PubMed ID: 25895871
[TBL] [Abstract][Full Text] [Related]
9. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
10. Exploring the tumor microenvironment with nanoparticles.
Miao L; Huang L
Cancer Treat Res; 2015; 166():193-226. PubMed ID: 25895870
[TBL] [Abstract][Full Text] [Related]
11. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications of spherical nucleic acids.
Barnaby SN; Sita TL; Petrosko SH; Stegh AH; Mirkin CA
Cancer Treat Res; 2015; 166():23-50. PubMed ID: 25895863
[TBL] [Abstract][Full Text] [Related]
13. Clinical developments in nanotechnology for cancer therapy.
Heidel JD; Davis ME
Pharm Res; 2011 Feb; 28(2):187-99. PubMed ID: 20549313
[TBL] [Abstract][Full Text] [Related]
14. Nanotheraputics.
Ravi Kumar MN; Blanco-Prieto MJ; Waterhouse DN
Cancer Lett; 2013 Jul; 334(2):155-6. PubMed ID: 23523611
[No Abstract] [Full Text] [Related]
15. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
16. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine: the promise and challenges in cancer chemotherapy.
Naguib YW; Cui Z
Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
[No Abstract] [Full Text] [Related]
18. Nanoparticle therapeutics for prostate cancer treatment.
Sanna V; Sechi M
Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
[TBL] [Abstract][Full Text] [Related]
19. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
